======= FBXO7 ======= == Gene Information == * **Official Symbol**: FBXO7 * **Official Name**: F-box protein 7 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=25793|25793]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y3I1|Q9Y3I1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=FBXO7&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FBXO7|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605648|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of the ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbxs class and it may play a role in regulation of hematopoiesis. Alternatively spliced transcript variants of this gene have been identified with the full-length natures of only some variants being determined. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Substrate recognition component of a SCF (SKP1-CUL1-F- box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Recognizes BIRC2 and DLGAP5. Plays a role downstream of PINK1 in the clearance of damaged mitochondria via selective autophagy (mitophagy) by targeting PRKN to dysfunctional depolarized mitochondria. Promotes MFN1 ubiquitination. {ECO:0000269|PubMed:15145941, ECO:0000269|PubMed:16510124, ECO:0000269|PubMed:23933751}. |F-box-like| |PI31 Prot N| |classical Lewy body| |Lewy neurite| |Lewy body corona| |glial cytoplasmic inclusion| |Lewy body core| |positive regulation of autophagy of mitochondrion| |negative regulation of oxidative stress-induced neuron death| |regulation of oxidative stress-induced neuron death| |negative regulation of cyclin-dependent protein serine/threonine kinase activity| |negative regulation of cyclin-dependent protein kinase activity| |mitochondrion disassembly| |autophagy of mitochondrion| |regulation of autophagy of mitochondrion| |negative regulation of cellular response to oxidative stress| |negative regulation of oxidative stress-induced cell death| |negative regulation of response to oxidative stress| |negative regulation of lymphocyte differentiation| |protein targeting to mitochondrion| |regulation of oxidative stress-induced cell death| |organelle disassembly| |SCF ubiquitin ligase complex| |establishment of protein localization to mitochondrion| |regulation of cellular response to oxidative stress| |protein localization to mitochondrion| |ubiquitin binding| |regulation of response to oxidative stress| |regulation of cyclin-dependent protein serine/threonine kinase activity| |negative regulation of leukocyte differentiation| |negative regulation of G1/S transition of mitotic cell cycle| |regulation of cyclin-dependent protein kinase activity| |ubiquitin ligase complex| |negative regulation of cell cycle G1/S phase transition| |positive regulation of mitochondrion organization| |positive regulation of autophagy| |negative regulation of protein serine/threonine kinase activity| |negative regulation of hemopoiesis| |negative regulation of lymphocyte activation| |regulation of G1/S transition of mitotic cell cycle| |regulation of cell cycle G1/S phase transition| |regulation of lymphocyte differentiation| |negative regulation of leukocyte activation| |regulation of mitochondrion organization| |negative regulation of cell activation| |negative regulation of neuron death| |negative regulation of mitotic cell cycle phase transition| |mitochondrial transport| |negative regulation of protein kinase activity| |negative regulation of cell cycle phase transition| |negative regulation of kinase activity| |ubiquitin-protein transferase activity| |autophagy| |process utilizing autophagic mechanism| |regulation of leukocyte differentiation| |negative regulation of transferase activity| |regulation of protein stability| |ubiquitin protein ligase binding| |protein polyubiquitination| |negative regulation of mitotic cell cycle| |regulation of neuron death| |negative regulation of cell cycle process| |regulation of autophagy| |protein targeting| |post-translational protein modification| |positive regulation of cellular catabolic process| |cellular component disassembly| |negative regulation of protein phosphorylation| |regulation of mitotic cell cycle phase transition| |establishment of protein localization to organelle| |positive regulation of catabolic process| |negative regulation of immune system process| |mitochondrion organization| |negative regulation of phosphorylation| |regulation of cell cycle phase transition| |regulation of hemopoiesis| |protein kinase binding| |protein heterodimerization activity| |regulation of neuron projection development| |regulation of lymphocyte activation| |regulation of protein serine/threonine kinase activity| |ubiquitin-dependent protein catabolic process| |modification-dependent protein catabolic process| |modification-dependent macromolecule catabolic process| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |negative regulation of cell cycle| |proteolysis involved in cellular protein catabolic process| |negative regulation of protein modification process| |protein-containing complex| |regulation of leukocyte activation| |cellular protein catabolic process| |positive regulation of organelle organization| |regulation of mitotic cell cycle| |regulation of cell activation| |regulation of neuron differentiation| |protein catabolic process| |protein ubiquitination| |regulation of plasma membrane bounded cell projection organization| |regulation of cell projection organization| |negative regulation of cell differentiation| |regulation of cellular response to stress| |protein localization to organelle| |regulation of cell cycle process| |protein modification by small protein conjugation| |negative regulation of catalytic activity| |regulation of protein kinase activity| |regulation of neurogenesis| |regulation of cellular catabolic process| |regulation of kinase activity| |cellular macromolecule catabolic process| |regulation of nervous system development| |regulation of cell development| |negative regulation of developmental process| |regulation of transferase activity| |regulation of locomotion| |protein modification by small protein conjugation or removal| |negative regulation of cell death| |regulation of catabolic process| |intracellular protein transport| |negative regulation of cellular protein metabolic process| |macromolecule catabolic process| |organonitrogen compound catabolic process| |negative regulation of protein metabolic process| |negative regulation of molecular function| |regulation of cell cycle| |negative regulation of multicellular organismal process| |positive regulation of cellular component organization| |mitochondrion| |proteolysis| |regulation of organelle organization| |regulation of protein phosphorylation| |regulation of response to stress| |protein transport| |intracellular transport| |generation of neurons| |peptide transport| |amide transport| |cellular protein localization| |regulation of phosphorylation| |cellular macromolecule localization| |establishment of protein localization| |negative regulation of response to stimulus| |neurogenesis| |regulation of immune system process| |regulation of cell death| |organic substance catabolic process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |cellular catabolic process| |regulation of cell differentiation| |establishment of localization in cell| |regulation of protein modification process| |nitrogen compound transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp453|B02 10μM R08 exp453]]|-2.46| |[[:results:exp78|Pterostilbene 16μM R02 exp78]]|-2.36| |[[:results:exp281|Disulfiram 4.3μM R06 exp281]]|-2.1| |[[:results:exp360|Genistein 15μM R07 exp360]]|-2.04| |[[:results:exp71|KU-0063794 3.8μM R02 exp71]]|-2.01| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|-1.94| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 4/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|1/26| |breast|1/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|1/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2679 * **Expression level (log2 read counts)**: 6.36 {{:chemogenomics:nalm6 dist.png?nolink |}}